REFRACTORY GLIOBLASTOMA
Clinical trials for REFRACTORY GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for REFRACTORY GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take aim at deadly brain cancer
Disease control OngoingThis early-phase trial is testing a new type of personalized immunotherapy for patients with malignant brain tumors (gliomas) that have returned or stopped responding to standard treatments. Doctors collect a patient's own immune cells (T-cells), genetically modify them in a lab …
Matched conditions: REFRACTORY GLIOBLASTOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Last-Hope treatment offered for aggressive brain cancer patients
Disease control NO_LONGER_AVAILABLEThis program provided gallium maltolate (GaM) capsules to adults with glioblastoma that had returned or stopped responding to standard treatments. Patients took one capsule daily by mouth at home for 28-day cycles. The goal was to offer a potential treatment option when no other …
Matched conditions: REFRACTORY GLIOBLASTOMA
Sponsor: Imaging Biometrics, LLC • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC